黑色素瘤分泌转化生长因子-β2导致表皮AMBRA1缺失,威胁表皮完整性并促进肿瘤溃疡形成
研究探讨黑色素瘤旁分泌TGF-β2是否导致覆盖肿瘤的表皮AMBRA1缺失及表皮完整性破坏。免疫组化分析109例AJCC各期黑色素瘤的AMBRA1与TGF-β2,并在30例或42例AJCC I期黑色素瘤中分别分析TGF-β2与claudin-1,另在42例黑色素瘤中分析溃疡前证据并于原代角质形成细胞中评估TGF-β2信号。结果提示TGF-β2经旁分泌机制引起AMBRA1缺失、表皮完整性下降,促进表皮糜烂与肿瘤溃疡。
要点
- 肿瘤TGF-β2升高与瘤周AMBRA1缺失、溃疡、AMLo高危状态及转移相关。
- TGF-β2处理角质形成细胞可下调AMBRA1、loricrin与claudin-1。
- 瘤周表皮AMBRA1缺失与claudin-1降低、角化不全及真皮表皮交界裂隙形成相关。
核心结论
- 数据提示一种旁分泌机制:TGF-β2使覆盖高危AJCC早期黑色素瘤的表皮AMBRA1缺失、表皮完整性下降,从而促进表皮糜烂和肿瘤溃疡。
研究设计与样本
- 免疫组化分析109例AJCC各期黑色素瘤的AMBRA1与TGF-β2。
- 在30例AJCC I期黑色素瘤中分析TGF-β2,在42例AJCC I期黑色素瘤中分析claudin-1,均有已知AMBRA1与loricrin(AMLo)表达。
- 在42例黑色素瘤中分析溃疡前证据,并在原代角质形成细胞中评估TGF-β2信号。
主要发现
- 肿瘤TGF-β2升高与瘤周AMBRA1缺失显著相关(P < 0·05)。
- 肿瘤TGF-β2升高与溃疡显著相关(P < 0·001),与AMLo高危状态显著相关(P < 0·05),与转移显著相关(P < 0·01)。
- TGF-β2处理角质形成细胞导致AMBRA1、loricrin和claudin-1下调。
- 敲低AMBRA1与claudin-1表达下降及角质形成细胞增殖增加相关(P < 0·05)。
- 瘤周表皮AMBRA1缺失与claudin-1表达下降(P < 0·05)、角化不全(P < 0·01)及真皮表皮交界裂隙形成(P < 0·05)相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: For patients with early American Joint Committee on Cancer (AJCC)-stage melanoma the combined loss of the autophagy regulatory protein AMBRA1 and the terminal differentiation marker loricrin in the peritumoral epidermis is associated with a significantly increased risk of metastasis. OBJECTIVES: The aim of the present study was to evaluate the potential contribution of melanoma paracrine transforming growth factor (TGF)-β signalling to the loss of AMBRA1 in the epidermis overlying the primary tumour and disruption of epidermal integrity. METHODS: Immunohistochemistry was used to analyse AMBRA1 and TGF-β2 in a cohort of 109 AJCC all-stage melanomas, and TGF-β2 and claudin-1 in a cohort of 30 or 42 AJCC stage I melanomas, respectively, with known AMBRA1 and loricrin (AMLo) expression. Evidence of pre-ulceration was analysed in a cohort of 42 melanomas, with TGF-β2 signalling evaluated in primary keratinocytes. RESULTS: Increased tumoral TGF-β2 was significantly associated with loss of peritumoral AMBRA1 (P < 0·05), ulceration (P < 0·001), AMLo high-risk status (P < 0·05) and metastasis (P < 0·01). TGF-β2 treatment of keratinocytes resulted in downregulation of AMBRA1, loricrin and claudin-1, while knockdown of AMBRA1 was associated with decreased expression of claudin-1 and increased proliferation of keratinocytes (P < 0·05). Importantly, we show loss of AMBRA1 in the peritumoral epidermis was associated with decreased claudin-1 expression (P < 0·05), parakeratosis (P < 0·01) and cleft formation in the dermoepidermal junction (P < 0·05). CONCLUSIONS: Collectively, these data suggest a paracrine mechanism whereby TGF-β2 causes loss of AMBRA1 overlying high-risk AJCC early-stage melanomas and reduced epidermal integrity, thereby facilitating erosion of the epidermis and tumour ulceration.
引用
- Cosgarea I, McConnell AT, Ewen T, et al. Melanoma secretion of transforming growth factor-β2 leads to loss of epidermal AMBRA1 threatening epidermal integrity and facilitating tumour ulceration. Br J Dermatol. 2021. PMID: 34773645. doi:10.1111/bjd.20889
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。